Pfizer Drug-Pricing Deal: More Upside For PFE Stock?
1. Pfizer stock priced around $25 is undervalued compared to the market. 2. Recent policy changes could lead to further upside potential for PFE. 3. Pfizer's revenue increased by 13.5% over the past 12 months. 4. Strong operational metrics support Pfizer's financial stability despite debt concerns. 5. A deal to lower drug prices may enhance Pfizer's market position.